Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 5.01 M22.93 M7.35 M6.66 M 41.95 M Research & development ———— — Operating income 45.99 M30.38 M8.49 M18.74 M 103.6 M Non-Operating Income, Total -127 K279 K-109 K-199 K -156 K Interest expense, net of interest capitalized ———— — Non-Operating Income, excl. Interest Expenses -127 K279 K-109 K-199 K -156 K Unusual income/expense ———— — Pretax income 42.91 M24.1 M18.77 M29.28 M 115.06 M Equity in earnings ———— — Taxes 4.81 M-3.4 M5.61 M8.41 M 15.44 M Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations 38.1 M27.49 M13.16 M20.87 M 99.62 M Discontinued operations ———— — Net income 38.1 M27.49 M13.16 M20.87 M 99.62 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders 35.91 M27.49 M13.16 M20.87 M 97.43 M Basic earnings per share (Basic EPS) 292.151.620.671.07 295.51 Diluted earnings per share (Diluted EPS) 292.151.620.671.07 295.51 Average basic shares outstanding 122.9 K16.96 M19.57 M17.24 M 53.89 M Diluted shares outstanding 122.9 K16.96 M19.57 M17.24 M 53.89 M EBITDA ——25.07 M35.65 M — EBIT 45.99 M30.38 M8.49 M18.74 M 103.6 M Cost of revenue 20.86 M21.19 M46.23 M43.24 M 131.52 M Other cost of goods sold ———— — Depreciation & amortization (cash flow) ——16.58 M16.91 M —